CORONA Remedies Limited
CORONA Remedies Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: CORONA and BSE: 544644 (ISIN INE02ZQ01018).
It has a market capitalisation of ₹12,293 crore, a last close of ₹2,010 on 2026-10-19.
Valuation: a price-to-earnings ratio of 61.77x, a price-to-book ratio of 16.46x, a dividend yield of 0.5%.
Profitability: return on equity of 24.8%, return on capital employed of 29.3%, an operating margin of 21.4%.
Balance sheet and ownership: debt-to-equity of 0.19x, promoter holding of 69.0%.
| Metric | Value |
|---|---|
| Market capitalisation | 12,293 |
| Last close | ₹2,010 |
| P/E (TTM) | 61.77x |
| P/B | 16.46x |
| Dividend yield | 0.5% |
| ROE (FY) | 24.8% |
| ROCE (FY) | 29.3% |
| Operating margin (TTM) | 21.4% |
| Debt / equity | 0.19x |
| Promoter holding | 69.0% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means